Private Equity in Anesthesia: Background and Long-Term Implications

Abstract

Features| September 2021 Private Equity in Anesthesia: Background and Long-Term Implications George Tewfik, MD, MBA, CPE; George Tewfik, MD, MBA, CPE Search for other works by this author on: This Site PubMed Google Scholar Richard P. Dutton, MD, MBA Richard P. Dutton, MD, MBA Search for other works by this author on: This Site PubMed Google Scholar ASA Monitor September 2021, Vol. 85, 29–31. https://doi.org/10.1097/01.ASM.0000791616.65509.57 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Twitter LinkedIn Cite Icon Cite Get Permissions Search Site Citation George Tewfik, Richard P. Dutton; Private Equity in Anesthesia: Background and Long-Term Implications. ASA Monitor 2021; 85:29–31 doi: https://doi.org/10.1097/01.ASM.0000791616.65509.57 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu nav search search input Search input auto suggest search filter All ContentAll PublicationsASA Monitor Search Advanced Search Topics: equity, investments Gordon Gekko, the brilliant but ruthless corporate titan at the center of Oliver Stone's 1987 film “Wall Street,” was a private equity investor, whose tactics earned him millions in the cutthroat world of mergers and acquisitions. The classic quote was “Greed is Good!” But is it? The answer matters because private equity ownership of anesthesia groups has been a reality for decades, with increasing prominence in recent years. A recent editorial in the New England Journal of Medicine discussed the expanding role of private equity in acquiring physician practices (N Engl J Med 2021;384:981-3). Private equity (PE) firms use capital sourced from pension funds, sovereign wealth funds, high net-worth individuals, and endowments to invest in promising businesses. PE investors typically seek a return of at least 20% to offset the risks involved, as future growth cannot be predicted with 100% accuracy (Ann Intern Med 2019;171:78). Investment... You do not currently have access to this content.